On April 15, 2020, CMS issued Ruling No. CMS-2020-01-R stating that Medicare will pay $100 for COVID-19 clinical diagnostic lab tests that use high-throughput technologies for rapid diagnosis of large numbers of COVID-19 cases. High-throughput lab tests can process more than 200 specimens a day and are expected to be instrumental in diagnosing and controlling the spread of COVID-19, especially in facilities such as nursing homes that house large numbers of people vulnerable to COVID-19. Medicare Administrative Contractors will continue to develop payment amounts for other COVID-19 laboratory tests.
By using this site, you agree to our updated Privacy Policy.
Necessary Cookies
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytical Cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.
